Antithymocyte Globulin in Reduced-Intensity Conditioning Regimen Allows a High Disease-Free Survival Exempt of Long-Term Chronic Graft-versus-Host Disease-Reference-Cited by-同舟云学术

Antithymocyte Globulin in Reduced-Intensity Conditioning Regimen Allows a High Disease-Free Survival Exempt of Long-Term Chronic Graft-versus-Host Disease

Published:2014-03 Issue:3 Volume:20 Page:370-374
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Devillier Raynier,Fürst Sabine,El-Cheikh Jean,Castagna Luca,Harbi Samia,Granata Angela,Crocchiolo Roberto,Oudin Claire,Mohty Bilal,Bouabdallah Reda,Chabannon Christian,Stoppa Anne-Marie,Charbonnier Aude,Broussais-Guillaumot Florence,Calmels Boris,Lemarie Claude,Rey Jèrôme,Vey Norbert,Blaise Didier

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Protective conditioning for acute graft-versus-host disease;Lowsky;N Engl J Med,2005

2. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects;McSweeney;Blood,2001

3. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen;Chakraverty;Blood,2002

4. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases;Slavin;Blood,1998

5. Reduced-intensity conditioning with Fludarabin, oral busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies;Blaise;Exp Hematol,2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2023-06-29

2. Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation;Transplantology;2023-02-17

3. Itacitinib Population Pharmacokinetics and Exposure‐Response in Patients With Acute Graft‐Versus‐Host Disease;The Journal of Clinical Pharmacology;2023-01-30

4. Am I Dreaming?;Patients’ Lived Experiences During the Transplant and Cellular Therapy Journey;2023

5. The impact of different doses of antithymocyte globulin conditioning on immune reconstitution upon hematopoietic stem cell transplantation;Transplant Immunology;2021-12